glp-1 and hrt for perimenopause glp 1 PSA all the women on GLP-1s hormone replacement therapy (HRT Tirzepatide leads to significant weight

SGLT2 inhibitors when used as an add-on therapy to metformin, insulin, thiazolidinediones, DPP-4 inhibitors, GLP-1 RAs, sulfonylureas, or metformin DPP-4 inhibitor were similarly effective in reducing A1c levels as when used in monotherapy (22,139)

Given diabetes' tremendous health and economic impact, new therapeutics that can better manage blood glucose with an improved safety profile will continue being priority treatment options for physicians and patients alike

Treatment Decision-Making Treatment decision-making can be guided by the different mechanisms of action of AOMs to ascertain the suitability of the therapy for the individual patient

Ongoing Support and Monitoring: Our team provides continuous guidance, with regular progress check-ins and expert advice to keep you on track

For Diabetes support groups visit the HealingWell Forum

These agents have been shown to reduce A1C (by 0.81.6%), body weight (by 13 kg), blood pressure, and lipids